NKGen Biotech Inc (NASDAQ:NKGN)’s traded shares stood at 0.52 million during the latest session, with the company’s beta value hitting 0.68. At the last check today, the stock’s price was $0.90, to imply an increase of 15.05% or $0.11 in intraday trading. The NKGN share’s 52-week high remains $4.06, putting it -351.11% down since that peak but still an impressive 77.78% since price per share fell to its 52-week low of $0.20. The company has a valuation of $32.15M, with an average of 0.39 million shares in intraday trading volume over the past 10 days and average of 1.36 million shares over the past 3 months.

NKGen Biotech Inc (NASDAQ:NKGN) trade information

After registering a 15.05% upside in the latest session, NKGen Biotech Inc (NKGN) has traded red over the past five days. The 5-day price performance for the stock is 84.62%, and 149.04% over 30 days. With these gigs, the year-to-date price performance is -67.09%. Short interest in NKGen Biotech Inc (NASDAQ:NKGN) saw shorts transact 0.87 million shares and set a 0.9 days time to cover.

NKGN Dividends

NKGen Biotech Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders

NKGen Biotech Inc insiders hold 42.32% of total outstanding shares, with institutional holders owning 12.19% of the shares at 21.14% float percentage. In total, 12.19% institutions holds shares in the company.